Evaluation of Platelet-rich Fibrin for Revascularization of Immature Permanent Teeth Versus Standard Apexification
NCT ID: NCT06693349
Last Updated: 2024-11-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
28 participants
INTERVENTIONAL
2020-01-02
2021-04-12
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* is the platelet-rich fibrin an effective mean for management of necrotic immature permanent teeth
* is the platelet-rich fibrin has a superior clinical and radiographic effects than calcium hydroxide apexification participants were treated either by platelet-rich fibrin revascularisation or calcium hydroxide apexification
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Regenerative Ability of Immature Necrotic Permanent Teeth Using Different Scaffolds
NCT06693739
Efficacy of Combined Blood Clot and Platelet Rich Fibrin Scaffolds in Regeneration of Necrotic Immature Permanent Teeth
NCT04390854
Platelet Rich Fibrin(PRF) Injection for Treatment of Dental Pulp Exposure:Randomized Clinical Trial
NCT04330768
Treated Dentine Matrix and Platelet Rich Fibrin in Induction of Root Formation of Non-Vital Immature Permanent Teeth
NCT05775081
Treatment of Deficient Interdental Papilla Using Albumin-platelets Rich Fibrin
NCT06842277
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Inclusion and diagnostic criteria:
A total of 28 children, including both boys and girls, were recruited through daily pa-tient screenings in the Clinics of Pediatric Dentistry and dental public health department, Faculty of Dentistry at Mansoura University, following specific inclusion and diagnostic criteria:
* Patients were free of chronic systemic diseases.
* Clinically, a negative response to electric pulp sensibility testing confirmed the pres-ence of immature necrotic permanent teeth.
* Teeth were categorized as uncontaminated if, during the examination, there were no signs of pain, no tenderness during apical percussion, no tenderness of adjacent soft tissues, and no history of open sinus, fistula or swelling.
* Radiographically, teeth were with roots exhibiting thin dentin walls and open apical foramina larger than 1 mm, along with apical periodontitis (considered as contami-nated) or without apical periodontitis (considered as uncontaminated).
Patients' allocation:
The included 28 children were divided into two main groups, each consisting of 14 children: Group I (contaminated teeth) and Group II (uncontaminated teeth). Within each group, children were further divided into two subgroups based on the treatment tech-nique. The allocation was determined through simple randomization, resulting in a Platelet-Rich Fibrin subgroup (n=7 for each) and a Calcium Hydroxide (CH) apexification subgroups (control) (n=7 for each),
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Contaminated immature permanent teeth
treatment of contaminated immature permanent teeth through either revascularization or apexification procedures
the effect of platelet-rich fibrin in treatment of contaminated and uncontaminated immature permanent teeth
this procedure was anticipated to give superior effects than other procedure used in this study
the effect of apexification in treatment of contaminated and uncontaminated immature permanent teeth
this procedure was anticipated to be replaced by other procedure be used in this study
uncontaminated immature permanent teeth
treatment of uncontaminated immature permanent teeth through either revascularization or apexification procedures
the effect of platelet-rich fibrin in treatment of contaminated and uncontaminated immature permanent teeth
this procedure was anticipated to give superior effects than other procedure used in this study
the effect of apexification in treatment of contaminated and uncontaminated immature permanent teeth
this procedure was anticipated to be replaced by other procedure be used in this study
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
the effect of platelet-rich fibrin in treatment of contaminated and uncontaminated immature permanent teeth
this procedure was anticipated to give superior effects than other procedure used in this study
the effect of apexification in treatment of contaminated and uncontaminated immature permanent teeth
this procedure was anticipated to be replaced by other procedure be used in this study
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Clinically, a negative response to electric pulp sensibility testing confirmed the pres-ence of immature necrotic permanent teeth.
* Teeth were categorized as uncontaminated if, during the examination, there were no signs of pain, no tenderness during apical percussion, no tenderness of adjacent soft tissues, and no history of open sinus, fistula or swelling.
* Radiographically, teeth were with roots exhibiting thin dentin walls and open apical foramina larger than 1 mm, along with apical periodontitis (considered as contami-nated) or without apical periodontitis (considered as uncontaminated).
7 Years
13 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mansoura University
OTHER
Mohammed Nasser Alhajj
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mohammed Nasser Alhajj
Assistant Professor Dr. Mohammed Nasser Alhajj
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mansoura University
Al Mansurah, Mansoura, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
11111218
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.